Isolation of a transformation-defective mutant of the McDonough strain of feline sarcoma virus exhibiting tyrosine kinase activity in vitro but not in vivo
- PMID: 2835515
- PMCID: PMC253315
- DOI: 10.1128/JVI.62.6.2150-2157.1988
Isolation of a transformation-defective mutant of the McDonough strain of feline sarcoma virus exhibiting tyrosine kinase activity in vitro but not in vivo
Abstract
NRK cells transformed by the McDonough strain of feline sarcoma virus (SM-FeSV) were mutagenized by the use of 5'-azacytidine. Four cell lines expressing different transformation-defective phenotypes were isolated. Superinfection of these cell lines with simian sarcoma-associated virus (SSAV) led in three instances to the recovery of transforming virus particles carrying an intact fms gene. A nonconditional transformation-defective virus, designated td26-SM-FeSV (SSAV), was isolated from one of the cell lines. NRK cells infected with this mutant contained actin cables and fibronectin networks and exhibited normal cell morphology. Such cells formed only small colonies in soft agar and exhibited a mitogenic activity similar to that of noninfected cells. Cells infected with td26-SM-FeSV (SSAV) synthesized a gag-fms fusion glycoprotein (gp180gag-fms). This polypeptide was processed in the normal manner into the intracellular gp120v-fms and a transformation-defective gp140td-v-fms which was expressed at the surface of infected cells. This species had an increased electrophoretic mobility on polyacrylamide gels compared with the molecule from wild-type virus.gp140td-v-fms had endo-beta-N-acetylglucosaminidase H-resistant carbohydrate side chains. No tyrosine kinase activity was detectable in vivo in td26-SM-FeSV (SSAV)-infected cells even when the cells were treated with sodium orthovanadate. In vitro, fms molecules from td26-SM-FeSV (SSAV)-infected cells exhibited tyrosine kinase activity as determined by autophosphorylation and phosphorylation of exogenous (poly)Glu-Tyr. At low ATP concentrations (less than 5 microM) this in vitro tyrosine kinase activity was significantly reduced compared with that of the wild-type counterpart.
Similar articles
-
McDonough feline sarcoma virus: characterization of the molecularly cloned provirus and its feline oncogene (v-fms).J Virol. 1982 Feb;41(2):489-500. doi: 10.1128/JVI.41.2.489-500.1982. J Virol. 1982. PMID: 6281462 Free PMC article.
-
A new acute transforming feline retrovirus with fms homology specifies a C-terminally truncated version of the c-fms protein that is different from SM-feline sarcoma virus v-fms protein.J Virol. 1986 Oct;60(1):194-203. doi: 10.1128/JVI.60.1.194-203.1986. J Virol. 1986. PMID: 3018286 Free PMC article.
-
Transformation of chicken fibroblasts by the v-fms oncogene.Virology. 1990 Oct;178(2):401-9. doi: 10.1016/0042-6822(90)90337-q. Virology. 1990. PMID: 2171188
-
Transforming mechanism of the feline sarcoma virus encoded v-fms oncogene product.Behring Inst Mitt. 1991 Jul;(89):93-9. Behring Inst Mitt. 1991. PMID: 1834054 Review.
-
Fusion proteins in retroviral transformation.Adv Cancer Res. 1985;43:205-39. doi: 10.1016/s0065-230x(08)60947-1. Adv Cancer Res. 1985. PMID: 2986428 Review. No abstract available.
Cited by
-
Tyrosine 807 of the v-Fms oncogene product controls cell morphology and association with p120RasGAP.J Virol. 1995 Oct;69(10):6010-20. doi: 10.1128/JVI.69.10.6010-6020.1995. J Virol. 1995. PMID: 7666506 Free PMC article.
-
Influence of tyrosine residues Y705 and Y807 on the transforming potency of the v-fms oncogene product of feline sarcoma virus.Arch Virol. 1995;140(1):179-86. doi: 10.1007/BF01309733. Arch Virol. 1995. PMID: 7646343
-
Reassessment of the v-fms sequence: threonine phosphorylation of the COOH-terminal domain.J Virol. 1991 Nov;65(11):6181-7. doi: 10.1128/JVI.65.11.6181-6187.1991. J Virol. 1991. PMID: 1833563 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous